Loading
Latest filing published 01 Feb 2022 for IMARA Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Kenneth Attie is known so far (1 February 2022): a share grant, in Enliven Therapeutics, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration